Folate (B9) production

Some bacteria in your colon make folate, the vitamin your cells need to build DNA and form healthy red blood cells. This stool result estimates your gut community's genetic capacity to make it. The lab reads microbial DNA using shotgun metagenomic sequencing, then analyzes the genes associated with that function.

This is an exploratory microbiome measurement. Its value for diagnosing disease, choosing supplements or monitoring treatment hasn't been established, and there is no validated health target for the result.

What the Result Reflects

Your cells depend on an outside supply of folate, mostly from food and supplements absorbed in the small intestine. Gut bacteria differ in how they obtain it. Some can make all the necessary starting materials themselves; others need ingredients supplied by food or neighboring microbes.

Laboratory studies have identified folate-producing strains within Bifidobacterium, Lactobacillus and other bacterial groups. Production varies by strain and growth conditions. In experiments with individual bacteria, some strains switched between consuming and producing folate as their growth conditions changed.

The genes in your stool describe production potential. Actual output also depends on whether those genes are active, which ingredients are available and how much folate other microbes consume. The result therefore doesn't quantify how much vitamin reaches your blood or colon lining. Stool also samples a different microbial community from one collected directly from the gut wall.

How This Differs From Blood Folate

Most dietary folate is absorbed in the small intestine. Absorption can also occur in the colon: in an experiment involving six adults, a labeled form of folate placed directly into the first part of the colon subsequently appeared in blood. That experiment established that colonic absorption is possible. It didn't measure how much folate each person's bacteria normally supplied.

A study of 200 adults examined a related but different measurement. Researchers grew stool bacteria under laboratory conditions for 24 hours and measured the folate they produced. Output wasn't associated with serum folate or blood homocysteine, and diet quality didn't predict it. Higher output was associated with lower bacterial diversity and greater abundance of Bacteroides, Sutterella and Parasutterella.

Those findings concern production in a culture dish, so they don't directly validate this DNA-based estimate. They do show why bacterial production and your nutritional status need separate assessment. Blood folate tests measure the vitamin itself.

What the Crohn's Disease Study Found

A study of 196 people with Crohn's disease found lower abundance of genes for 105 microbial pathways in samples collected during flares compared with samples collected before or after a flare. These included pathways involved in making folate and other B vitamins.

Each person contributed one stool sample. The researchers compared different people at different stages of disease; they didn't follow an individual's folate-making capacity through a flare and recovery. Medication use, including steroids, also complicated the analysis.

This supports an association between active Crohn's disease and altered bacterial functions. It doesn't establish that a falling result predicts your next flare, measures its severity or proves that restoring the pathway would reduce inflammation.

Findings in Other Conditions

Other studies have reported differences in folate-related bacterial functions, but their methods and populations vary. Some measured microbial genes directly. Others identified bacteria using a short DNA marker called 16S and then predicted their functions from reference genomes.

A separate observational study in adults found that greater frailty was associated with more abundant folate-making pathways. In a comparison of about 3,500 children and adults, children had higher predicted folate-making capacity. That age comparison also used functions inferred from 16S profiles, and it didn't establish why the groups differed.

These findings don't establish a universally beneficial direction for your result. A higher estimate can occur in several different biological settings. Adding a diversity score doesn't turn it into a validated measure of nutritional health or disease risk.

Folate in the Colon Lining

Folate in colon tissue is another distinct measurement. In a screening study, tissue biopsies were available from 813 women. Those with the highest tissue folate concentrations had fewer advanced adenomas. Adenomas are growths that can sometimes develop into cancer.

The study measured folate in the tissue itself and couldn't determine how much came from bacteria. Its findings don't establish that a higher stool production estimate protects against colorectal cancer.

When Results Can Be Misleading

Bacterial abundance can vary considerably between samples. In a study that collected stool daily from 20 women, about four fifths of the bacterial groups examined varied more within a person than between people, and some changed up to 100-fold over the study period. Those figures describe bacterial counts, not the variability of this particular folate-capacity estimate.

• Stool consistency: stool moisture was an important contributor to day-to-day microbial variation in that study. A loose or hard sample can represent a different gut environment.
• DNA extraction: laboratory methods differ in how effectively they break open bacteria. One comparison found this was the largest technical contributor to differences in microbial profiles, particularly for bacteria with tougher cell walls.
• Sequencing and analysis: estimates depend on the microbial DNA recovered, the depth of sequencing and the reference databases used to assign functions. Results from different methods or laboratories aren't interchangeable.
• Recent changes: antibiotics, other medications, probiotics, diet changes and gastrointestinal illness can alter the sampled community. Their effects don't establish that a change in this score is beneficial or harmful.
• Potential versus activity: detecting folate-related genes doesn't establish that those genes are active or that the resulting vitamin is available to you.

What a Change Over Time Can Mean

Repeated samples can describe changes in your microbiome under comparable collection and laboratory conditions. There is no established amount of change in this marker that represents improved nutrition, reduced inflammation or better long-term health.